[go: up one dir, main page]

MXPA02012255A - Nucleotide sequence of influenza a/udorn/72 (h3n2) genome. - Google Patents

Nucleotide sequence of influenza a/udorn/72 (h3n2) genome.

Info

Publication number
MXPA02012255A
MXPA02012255A MXPA02012255A MXPA02012255A MXPA02012255A MX PA02012255 A MXPA02012255 A MX PA02012255A MX PA02012255 A MXPA02012255 A MX PA02012255A MX PA02012255 A MXPA02012255 A MX PA02012255A MX PA02012255 A MXPA02012255 A MX PA02012255A
Authority
MX
Mexico
Prior art keywords
influenza
udorn
genome
nucleotide sequence
sequence
Prior art date
Application number
MXPA02012255A
Other languages
Spanish (es)
Inventor
Jose M Galarza
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of MXPA02012255A publication Critical patent/MXPA02012255A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)

Abstract

The complete nucleotide sequence of each of the eight segments of the negative strand Influenza A virus strain A/Udorn/72 (H3N2) is disclosed, which provides the complete sequence of the genome in antigenomic message sense. The sequence is useful in diagnosis and may be modified by mutation to generate new influenza A variant strains.
MXPA02012255A 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome. MXPA02012255A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21365000P 2000-06-23 2000-06-23
PCT/US2001/019826 WO2002000884A2 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome

Publications (1)

Publication Number Publication Date
MXPA02012255A true MXPA02012255A (en) 2003-04-25

Family

ID=22795944

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012255A MXPA02012255A (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome.

Country Status (10)

Country Link
EP (1) EP1292614A2 (en)
JP (1) JP2004514415A (en)
KR (1) KR20030013451A (en)
CN (1) CN1437612A (en)
AU (1) AU2001270033A1 (en)
BR (1) BR0111819A (en)
CA (1) CA2410284A1 (en)
IL (1) IL153005A0 (en)
MX (1) MXPA02012255A (en)
WO (1) WO2002000884A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160759A1 (en) * 2002-09-28 2006-07-20 Jianzhu Chen Influenza therapeutic
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20120122103A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
BRPI0518568A2 (en) * 2004-12-24 2008-11-25 Solvay Pharm Bv Method for producing a replicative influenza virus particle without the use of helper virus, replicative influenza virus particle, Cell, composition, use of a composition, Method for generating immunological protection against infection of an individual with an influenza virus, , Nucleic acid
CN103451158B (en) * 2005-04-21 2018-11-23 佛罗里达大学研究基金公司 The substance and method controlled for respiratory disease in canid
EP1877418B1 (en) 2005-05-06 2013-11-20 Gen-Probe Incorporated Compositions and assays to detect influenza virus a nucleic acids
US20100190842A1 (en) * 2007-04-12 2010-07-29 Alnylam Pharmaceuticals, Inc. Influenza polynucleotides, expression constructs, compositions, and methods of use
KR100913425B1 (en) 2007-05-14 2009-08-21 녹십자수의약품(주) Influenza Virus and Immunogenic Compositions Comprising the Same
KR20160017131A (en) * 2008-12-19 2016-02-15 유럽피안 몰레큘러 바이올로지 래보러토리 Polypeptide fragments comprising endonuclease activity and their use
EP3301195B1 (en) 2010-07-12 2022-11-02 Gen-Probe Incorporated Compositions and assays to detect 2009 swine h1n1 influenza a virus nucleic acid
CN107488743A (en) * 2017-08-30 2017-12-19 上海伯杰医疗科技有限公司 H3N2 subtype influenza virus genome sequencing methods

Also Published As

Publication number Publication date
BR0111819A (en) 2004-01-06
IL153005A0 (en) 2003-06-24
EP1292614A2 (en) 2003-03-19
CN1437612A (en) 2003-08-20
KR20030013451A (en) 2003-02-14
AU2001270033A1 (en) 2002-01-08
JP2004514415A (en) 2004-05-20
WO2002000884A2 (en) 2002-01-03
WO2002000884A3 (en) 2002-08-15
CA2410284A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
MXPA02012255A (en) Nucleotide sequence of influenza a/udorn/72 (h3n2) genome.
ES2526191T3 (en) Method to produce infectious influenza B virus in cell culture
LU91367I2 (en) A complete inactivated influenza virus vaccine prepared from a germ strain produced by using reverse genetics and optionally including an adjuvant
BRPI0518568A2 (en) Method for producing a replicative influenza virus particle without the use of helper virus, replicative influenza virus particle, Cell, composition, use of a composition, Method for generating immunological protection against infection of an individual with an influenza virus, , Nucleic acid
NO20030219D0 (en) Codon-optimized papillomavirus sequences
ATE308550T1 (en) USES OF SULFATED FUCO-OLIGOSACCHARIDES FOR PLANT PROTECTION
JP2004509903A5 (en)
AR069653A2 (en) ASPERGILLUS ORIGINAL GLUCOAMYLASE VARIANTE, A DNA CONSTRUCTION, A RECOMBINANT EXPRESSION VECTOR, A CELL, A PROCESS TO CONVERT ALMIDON, USE OF A GLUCOAMYLASE VARIANTE FOR A FERMENTATION AND METHOD PROCESS TO ALTER THE TERMINATION.
CA2154023A1 (en) Recombinant infectious non-segmented negative strand rna virus
DK0679187T4 (en) Method for Extracting Native Oligomeric Glycosylated Ectodomains from Viral Membrane Proteins and Their Use, Especially as a Vaccine against HIV
ATE553191T1 (en) CODONE-OPTIMIZED ALKALINE PHOSPHATASE AND ITS EXPRESSION IN YEAST
BR9811151A (en) Bacterial strain belonging to the genus corynebacterium, a gene encoding glutamine-oxoglutarate amino transferase, and a process to produce l-glutamic acid
HUP0303431A2 (en) Live attenuated strains of prrs virus
DE60110047D1 (en) TOOTH PROCESSOR CELL AND METHOD FOR THE PRODUCTION THEREOF
HUP0303878A2 (en) Smallpox vaccine
Schlesinger et al. Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: evidence and speculation
BR0001342A (en) Process for the production of l-amino acids by fermentation using corineform bacteria
DE60231821D1 (en) RECOMBINANT TOLLWOOD VACCINES AND METHOD FOR THEIR PREPARATION AND USE
JP2007516721A5 (en)
BR0002493A (en) Process for the preparation of l-amino acids by fermentation and nucleotide sequences encoding the accda gene
HUP0400150A2 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
BR0100816A (en) Bacterium belonging to the genus methilophilus, and, process to produce l-phenylalanine
EP1309342A4 (en) PRODUCTION OF CHIMERIC HUMAN PAPILLOMAVIRUS
ATE290090T1 (en) YEAST STRAIN FOR TESTING THE GENO- AND CYTOTOXICITY OF COMPLEX ENVIRONMENTAL CONTAMINATIONS
EP1334176A4 (en) Microorganisms producing l-glutamine and processes for producing l-glutamine using the same